Search
IRIDEX Corp
IRIXAdd to Watchlist
1.130USD
-0.040-3.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
19.27MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-3.42%
5 Days
0.00%
1 Month
-1.74%
6 Months
-3.42%
Year to Date
-0.88%
1 Year
+21.51%
Key Figures
1.150Open
1.170High
27.47KVolume
LossP/E TTM
53.37P/E Dynamic
--Dividend TTM
0.16%Turnover Ratio
1.170Prev. Close
1.120Low
23.02KTurnover
LossP/E Static
-14.61P/B
0.00%Div Yield TTM
-10.48%ROA
1.64852wk High
1.57Volume Ratio
-8.91MNet Profit
17.05MShares
-0.1915EPS TTM
0.64Beta
-870.85%ROE
0.86952wk Low
4.27%Amplitude
40.18%Gross Margin
19.27MMarket Cap
0.44Reward/Risk
4.00%Risk Rate
TradingKey Stock Score of IRIDEX Corp
Currency: USD Updated: 2026-07-02Key Insights
IRIDEX Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 116 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.75.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IRIDEX Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
IRIDEX Corp Highlights
StrengthsRisks
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Growing
The company is in a growing phase, with the latest annual income totaling USD 52.67M.
Undervalued
The company’s latest PE is -5.90, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.69M shares, increasing 7.01% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.40.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.750
Target Price
+135.04%
Upside Space
IRIDEX Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IRIDEX Corp Info
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Ticker SymbolIRIX
CompanyIRIDEX Corp
CEOMercer (Patrick)
Websitehttps://www.iridex.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of IRIDEX Corp (IRIX)?
The current price of IRIDEX Corp (IRIX) is 1.13.
What is the symbol of IRIDEX Corp?
The ticker symbol of IRIDEX Corp is IRIX.
What is the 52-week high of IRIDEX Corp?
The 52-week high of IRIDEX Corp is 1.65.
What is the 52-week low of IRIDEX Corp?
The 52-week low of IRIDEX Corp is 0.87.
What is the market capitalization of IRIDEX Corp?
The market capitalization of IRIDEX Corp is 19.27M.
Is IRIDEX Corp (IRIX) currently rated as Buy, Hold, or Sell?
According to analysts, IRIDEX Corp (IRIX) has an overall rating of Buy, with a price target of 2.75.
What is the Earnings Per Share (EPS TTM) of IRIDEX Corp (IRIX)?
The Earnings Per Share (EPS TTM) of IRIDEX Corp (IRIX) is -0.26.